Neuroprotective effects of uridine in a rat model of neonatal hypoxic-ischemic encephalopathy

Neuroscience Letters

Volumn 542, Issue , 2013, Pages 65-70

  Cansev, Mehmet ^a   Minbay, Zehra ^a   Goren, Bulent ^a   Yaylagul, Esra Orenlili ^a   Cetinkaya, Merih ^a   Koksal, Nilgun ^a   Alkan, Tulin ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Hypoxic ischemic encephalopathy; Neonatal; Neuroprotection; Rat; Uridine

Indexed keywords

CASPASE 3; URIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEMISPHERE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOREACTIVITY; NEUROPROTECTION; NEWBORN; NEWBORN DISEASE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; BRAIN INFARCTION; CASPASE 3; CEREBRAL CORTEX; HYPOXIA-ISCHEMIA, BRAIN; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; URIDINE;

EID: 84876725421     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.02.035     Document Type: Article

References (36)

1. Adibhatla R.M., Hatcher J.F. Cytidine 5'-diphosphocholine (CDP-Choline) in stroke and other CNS disorders. Neurochem. Res. 2005, 30:15-23.
2. Altman J., Bayer S.A. Atlas of Prenatal Rat Brain Development 1995, CRC Press, Boca Raton, FL.
3. Arthur D.B., Georgi S., Akassoglou K., Insel P.A. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J. Neurosci. 2006, 26:3798-3804.
4. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res. Rev. 2006, 52:389-397.
5. Cansev M. Involvement of uridine-nucleotide-stimulated P2Y receptors in neuronal growth and function. Cent. Nerv. Sys. Agents Med. Chem. 2007, 7:223-229.
6. Cansev M., Marzloff G., Sakamoto T., Ulus I.H., Wurtman R.J. Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups. Dev. Neurosci. 2009, 31:181-192.
7. Cansev M., Ulus I.H., Wang L., Maher T.J., Wurtman R.J. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. Neurosci. Res. 2008, 62:206-209.
8. Cansev M., Watkins C.J., van der Beek E.M., Wurtman R.J. Oral Uridine 5' monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 2005, 1058:101-108.
9. Chia J., Baddeley A. Accuracy of estimates of volume fraction. Image Anal. Stereol. 2000, 19:199-204.
10. Choi J.W., Yoo B.K., Shin C.Y., Ryu M.K., Ryu J.H., el Kouni M.H., Lee J.C., Kim W.K., Ko K.H. Uridine prevents the glucose deprivation-induced death of immunostimulated astrocytes via the action of uridine phosphorylase. Neurosci. Res. 2006, 56:111-118.
11. Choi J.W., Shin C.Y., Choi M.S., Yoon S.Y., Ryu J.H., Lee J.C., Kim W.K., el Kouni M.H., Ko K.H. Uridine protects cortical neurons from glucose deprivation-induced death: possible role of uridine phosphorylase. J. Neurotrauma 2008, 25:695-707.
12. Ekinci N., Acer N., Akkaya A., Sankur S., Kabadayi T., Sahin B. Volumetric evaluation of the relations among the cerebrum, cerebellum and brain stem in young subjects: a combination of stereology and magnetic resonance imaging. Surg. Radiol. Anat. 2008, 30:489-494.
13. Fiedorowicz M., Makarewicz D., Stańczak-Mrozek K.I., Grieb P. CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia. Acta Neurobiol. Exp. 2008, 68:389-397.
14. Gundersen H.J., Bendtsen T.F., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J.R., Pakkenberg B., Sørensen F.B., Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988, 96:379-394.
15. Jacobs S.E., Morley C.J., Inder T.E., Stewart M.J., Smith K.R., McNamara P.J., Wright I.M., Kirpalani H.M., Darlow B.A., Doyle L.W. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch. Pediatr. Adolesc. Med. 2011, 165:692-700. Infant Cooling Evaluation Collaboration.
16. Kennedy E.M., Weiss S.B. The function of cytidine coenzymes in the biosynthesis of phospholipids. J. Biol. Chem. 1956, 222:193-214.
17. Kurinczuk J.J., White-Koning M., Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum. Dev. 2010, 86:329-338.
18. Lecca D., Ceruti S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem. Pharmacol. 2008, 75:1869-1881.
19. Leyva A., van Groeningen C.J., Kraal I., Gall H., Peters G.J., Lankelma J., Pinedo H.M. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Cancer Res. 1984, 44:5928-5933.
20. Mir C., Clotet J., Aledo R., Durany N., Argemi J., Lozano R., Cervos-Navarro J., Casals N. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J. Mol. Neurosci. 2003, 20:53-60.
21. Peters G.J., van Groeningen C.J., Laurensse E.J., Lankelma J., Leyva A., Pinedo H.M. Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites. Cancer Chemother. Pharmacol. 1987, 20:101-108.
22. Pooler A.M., Guez D.H., Benedictus R., Wurtman R.J. Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells. Neuroscience 2005, 134:207-214.
23. Richardson U.I., Watkins C.J., Pierre C., Ulus I.H., Wurtman R.J. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells. Brain Res. 2003, 971:161-167.
24. Sakamoto T., Cansev M., Wurtman R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007, 1182:50-59.
25. Tagin M.A., Woolcott C.G., Vincer M.J., Whyte R.K., Stinson D.A. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch. Pediatr. Adolesc. Med. 2012, 166:558-566.
26. Thorell L., Sjoberg L-B., Hernell O. Nucleotides in human milk: sources and metabolism by the newborn infant. Pediatric Res. 1996, 40:845-852.
27. Ulus I.H., Watkins C.J., Cansev M., Wurtman R.J. Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or release. Cell. Mol. Neurobiol. 2006, 26:563-577.
28. van Groeningen C.J., Peters G.J., Nadal J.C., Laurensse E., Pinedo H.M. Clinical and pharmacologic study of orally administered uridine. J. Natl. Cancer Inst. 1991, 83:437-441.
29. Vanucci S.J., Hagberg H. Hypoxia-ischemia in the immature brain. J. Exp. Biol. 2004, 207:3149-3154.
30. Vannucci R.C., Vanucci S.J. A model of perinatal hypoxic-ischemic brain damage. Ann. N.Y. Acad. Sci. 1997, 835:234-429.
31. Vannucci R.C., Vanucci S.J. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev. Neurosci. 2005, 27:81-86.
32. Volpe J.J. Hypoxic-ischemic encephalopathy. Neurology of the Newborn 2001, 245-480. WB Saunders, Philadelphia, PA. J.J. Volpe (Ed.).
33. Wintermark P. Current controversies in newer therapies to treat birth asphyxia. Int. J. Pediatr. 2011, 2011:848413.
34. Wurtman R.J., Cansev M., Sakamoto T., Ulus I.H. Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 2009, 29:59-87.
35. Wurtman R.J., Regan M., Ulus I.H., Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem. Pharmacol. 2000, 60:989-992.
36. Xiong T., Qu Y., Mu D., Ferriero D. Erythropoietin for neonatal brain injury: opportunity and challenge. Int. J. Dev. Neurosci. 2011, 29:583-591.